Company Name: Representative: Securities Code: For Inquiries, Contact: Telephone:

First Page		Document Content
Date: 2014-11-03 11:26:19 Endocrinology Menopause Menstrual cycle Middle age Shionogi Estrogen Dyspareunia Selective estrogen receptor modulator Vaginal lubrication Anatomy Human reproduction Medicine		Company Name: Representative: Securities Code: For Inquiries, Contact: Telephone: Add to Reading List Source URL: shionogi616.tew-staging.com Download Document from Source Website File Size: 66,08 KB Share Document on Facebook

	Menopause Menopause can be defined as occurring 12 months after your last menstrual period and marks the end of menstrual cycles. Menopause can transpire in your 40s or 50s, but the average age is 51. Menopause is a nat DocID: 1q7Sq - View Document
	www.astroglideaustralia.com Vaginal Dryness Astroglide is a personal lubricant for the genital area. It is formulated to simulate the body’s own lubricating secretions. Consider the benefits of using Astroglide® – i DocID: 1g4eK - View Document
	Shionogi receives Marketing Authorisation approval for Senshio® (ospemifene) in Europe for the treatment of moderate to severe symptomatic vulvar and vaginal atrophy (VVA) in post-menopausal women Osaka, Japan January 1 DocID: 1a1DJ - View Document
	FOR IMMEDIATE RELEASE U. S. FOOD AND DRUG ADMINISTRATION ACCEPTS SHIONOGI’S OSPEMIFENE NEW DRUG APPLICATION IN VULVAR AND VAGINAL ATROPHY Potential First Oral Alternative to Vaginal Estrogen Treatments FLORHAM PARK, N DocID: 19rXR - View Document
	Company Name: Representative: Securities Code: For Inquiries, Contact: Telephone: DocID: 19eEl - View Document